Patient Case Studies of GvHD
Provide detailed case studies highlighting the development, clinical presentation, multidisciplinary management, and outcomes of patients with acute and chronic GvHD following allo-HSCT.
Source: onclive.com
Page 2 - Agvhd News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Agvhd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Agvhd Today - Breaking & Trending Today
Retrospective Analysis Suggests Allo-HSCT Feasible for R/R DLBCL After CAR T Failure
Among the 10 patients in the retrospective analysis, the median overall survival after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) was 21 months.
Source: ajmc.com
Graft-versus-Host Disease Prophylaxis and Management
Focus on methods for preventing graft-versus-host disease (GvHD) following allo-HSCT, such as pharmacologic immune suppression and stem cell graft manipulation techniques.
Source: onclive.com
Transplant Complications and Survival Outcomes
Analyze risks and complications associated with allo-HSCT, including graft-versus-host disease, infections, relapse, and regimen-related toxicities.
Source: onclive.com
Acute Versus Chronic Graft-Versus-Host Disease (GVHD)
Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz distinguish acute from chronic graft-versus-host disease (GVHD), how such distinction has changed over the last decades, and provide an overview of consensus definitions for disease grading.
Source: onclive.com